Patient Safety
Investigations into the risks patients face on GLP-1 therapy: nutrient deficiencies, muscle loss, bone density, and the care gaps that endanger long-term health.
Investigation
The Nutrient Gap: 90% of GLP-1 Patients Are Deficient and Don't Know It
Severe appetite suppression reduces caloric intake by 30–40%, and micronutrient intake drops with it. Vitamin D, B12, magnesium deficiencies are near-universal.
Muscle Loss
The Muscle Crisis: Why Your GLP-1 Is Eating Your Muscles
25–40% of weight lost on GLP-1s is lean mass. Without resistance training and protein protocols, patients face sarcopenic obesity.
Featured Report
The Complete Physician's Protocol: What Your Provider Should Have Given You
Labs, protein targets, supplement stacks, training plans, and the discontinuation strategy that prevents regain.
Physician-Led Program · Lion MD
Compounded Semaglutide
Weekly injection. Appetite reduction + blood sugar regulation. Physician-monitored.
From $99/mo
Get Started →